Cargando…
Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712880/ https://www.ncbi.nlm.nih.gov/pubmed/34970502 http://dx.doi.org/10.3389/fonc.2021.823960 |
| _version_ | 1784623655053950976 |
|---|---|
| author | Kuo, Yuan-Hung Lu, Sheng-Nan Chen, Yen-Yang Kee, Kwong-Ming Yen, Yi-Hao Hung, Chao-Hung Hu, Tsung-Hui Chen, Chien-Hung Wang, Jing-Houng |
| author_facet | Kuo, Yuan-Hung Lu, Sheng-Nan Chen, Yen-Yang Kee, Kwong-Ming Yen, Yi-Hao Hung, Chao-Hung Hu, Tsung-Hui Chen, Chien-Hung Wang, Jing-Houng |
| author_sort | Kuo, Yuan-Hung |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8712880 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87128802021-12-29 Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis Kuo, Yuan-Hung Lu, Sheng-Nan Chen, Yen-Yang Kee, Kwong-Ming Yen, Yi-Hao Hung, Chao-Hung Hu, Tsung-Hui Chen, Chien-Hung Wang, Jing-Houng Front Oncol Oncology Frontiers Media S.A. 2021-12-14 /pmc/articles/PMC8712880/ /pubmed/34970502 http://dx.doi.org/10.3389/fonc.2021.823960 Text en Copyright © 2021 Kuo, Lu, Chen, Kee, Yen, Hung, Hu, Chen and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Kuo, Yuan-Hung Lu, Sheng-Nan Chen, Yen-Yang Kee, Kwong-Ming Yen, Yi-Hao Hung, Chao-Hung Hu, Tsung-Hui Chen, Chien-Hung Wang, Jing-Houng Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis |
| title | Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis |
| title_full | Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis |
| title_fullStr | Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis |
| title_full_unstemmed | Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis |
| title_short | Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis |
| title_sort | corrigendum: real-world lenvatinib versus sorafenib in patients with advanced hepatocellular carcinoma: a propensity score matching analysis |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712880/ https://www.ncbi.nlm.nih.gov/pubmed/34970502 http://dx.doi.org/10.3389/fonc.2021.823960 |
| work_keys_str_mv | AT kuoyuanhung corrigendumrealworldlenvatinibversussorafenibinpatientswithadvancedhepatocellularcarcinomaapropensityscorematchinganalysis AT lushengnan corrigendumrealworldlenvatinibversussorafenibinpatientswithadvancedhepatocellularcarcinomaapropensityscorematchinganalysis AT chenyenyang corrigendumrealworldlenvatinibversussorafenibinpatientswithadvancedhepatocellularcarcinomaapropensityscorematchinganalysis AT keekwongming corrigendumrealworldlenvatinibversussorafenibinpatientswithadvancedhepatocellularcarcinomaapropensityscorematchinganalysis AT yenyihao corrigendumrealworldlenvatinibversussorafenibinpatientswithadvancedhepatocellularcarcinomaapropensityscorematchinganalysis AT hungchaohung corrigendumrealworldlenvatinibversussorafenibinpatientswithadvancedhepatocellularcarcinomaapropensityscorematchinganalysis AT hutsunghui corrigendumrealworldlenvatinibversussorafenibinpatientswithadvancedhepatocellularcarcinomaapropensityscorematchinganalysis AT chenchienhung corrigendumrealworldlenvatinibversussorafenibinpatientswithadvancedhepatocellularcarcinomaapropensityscorematchinganalysis AT wangjinghoung corrigendumrealworldlenvatinibversussorafenibinpatientswithadvancedhepatocellularcarcinomaapropensityscorematchinganalysis |